NCT05105074View on ClinicalTrials.gov

Does the Use of Intrathecal Morphine Increase the Length of Hospital Stay in Fast Track Orthopedic Procedures?

NACompletedINTERVENTIONAL
Enrollment

104

Participants

Timeline

Start Date

January 19, 2019

Primary Completion Date

October 1, 2021

Study Completion Date

October 30, 2021

Conditions
Arthropathy of KneeArthropathy of Hip
Interventions
DRUG

Intrathecal Morphine

Group 1 - Patients will receive intrathecal morphine 100 mcg in addition to the standard dose of bupivacaine and 15 mcg of fentanyl for spinal anesthesia.

DRUG

Placebo

Group 2 - Patients will not receive intrathecal morphine. Patients will receive only bupivacaine and 15 mcg of fentanyl for spinal anesthesia.

Trial Locations (1)

M5G 1X5

Mount Sinai Hospital, Toronto

All Listed Sponsors
lead

Samuel Lunenfeld Research Institute, Mount Sinai Hospital

OTHER

NCT05105074 - Does the Use of Intrathecal Morphine Increase the Length of Hospital Stay in Fast Track Orthopedic Procedures? | Biotech Hunter | Biotech Hunter